Hypertension

The groundbreaking MaRS EXCITE program has announced its first three recipients of pre-market assessment of new health technologies

Canadian experts deliver their takes on LDL targets and risk assessment

There has been much discussion recently on the new guidelines for the treatment of blood cholesterol. But these discussions have largely missed two key words in the new guidelines: “patient preference.” This is an important transformation in guideline attitude, and here’s why.

First drug approved to treat rare type of pulmonary hypertension.

Here’s how you can apply this dietary concept to a wide range of clinical situations

When we dig a little deeper, we can do more for our patients